-
Product Insights
NewLikelihood of Approval Analysis for Metastatic Bile Duct Cancer
Overview How likely is it that the drugs in Metastatic Bile Duct Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Bile Duct Cancer Overview Cholangiocarcinoma, also known as bile...
-
Product Insights
NewLikelihood of Approval Analysis for Diabetic Retinopathy
Overview How likely is it that the drugs in Diabetic Retinopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diabetic Retinopathy Overview Diabetic retinopathy is a complication of diabetes that affects...
-
Product Insights
NewLikelihood of Approval Analysis for Paroxysmal Nocturnal Hemoglobinuria
Overview How likely is it that the drugs in Paroxysmal Nocturnal Hemoglobinuria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Paroxysmal Nocturnal Hemoglobinuria Overview Paroxysmal nocturnal hemoglobinuria is a rare disease...
-
Product Insights
NewLikelihood of Approval Analysis for Cholangitis
Overview How likely is it that the drugs in Cholangitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cholangitis Overview Cholangitis refers to inflammation of the bile ducts, which are tubes...
-
Case Studies
NewMountain Tourism – Case Study
Mountain Tourism Report Overview The mountain tourism case study offers detailed insights into the key destinations with opportunities and challenges faced by the industry. Mountains are important tourist destinations around the world and attract visitors for their picturesque beauty, sports attractions, and rich cultural and spiritual heritage. The expansion of transportation networks and digitalization has led to an increased interest in mountain tourism both for adventure and wellness. Mountain tourism allows tourists to witness and experience the environment in a...
-
Product Insights
NewLikelihood of Approval Analysis for Uveal Melanoma
Overview How likely is it that the drugs in Uveal Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveal Melanoma Overview Uveal melanoma, the most common intraocular tumor, is a...
-
Product Insights
NewLikelihood of Approval Analysis for Pancreatic Tumor
Overview How likely is it that the drugs in Pancreatic Tumor will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pancreatic Tumor Overview Pancreatic cancer refers to the carcinoma arising from the...
-
Product Insights
NewLikelihood of Approval Analysis for Uveitis
Overview How likely is it that the drugs in Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Uveitis Overview Uveitis is swelling and irritation of the uvea, the middle layer...
-
Product Insights
NewLikelihood of Approval Analysis for Proliferative Diabetic Retinopathy (PDR)
Overview How likely is it that the drugs in Proliferative Diabetic Retinopathy (PDR) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Proliferative Diabetic Retinopathy (PDR) Overview Proliferative diabetic retinopathy (PDR) is...
-
Product Insights
NewLikelihood of Approval Analysis for Glomerulonephritis
Overview How likely is it that the drugs in Glomerulonephritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Glomerulonephritis Overview Glomerulonephritis is also known as glomerular nephritis (GN) or glomerular disease....